For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
A toolkit for 2024 – Part 4 – Technology: New and emerging tools will benefit healthcare
A toolkit for 2024 – Part 4 – Technology: New and emerging tools will benefit healthcare

The world is rapidly changing, as is the practice of healthcare within it. Primary care has adapted to recent challenges but must be ready to face the next ones. In this four-part series, Jo Scott-Jones provides resources around equity, planetary health, continuity of care and technology, with the caveats of funding, workforce and workload – essentially, a toolkit to help you plan for the year ahead. Part 4 looks at technology
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Ministry of Social Development. The Social Report 2016 – Te pūrongo oranga tangata. Economic standard of living: Income inequality.
2. NIWA. Climate change and possible impacts for New Zealand.
3. Betty B, Scott-Jones J, Toop L. State of general practice in New Zealand. N Z Med J 2023;136(1582):8–10.
4. McBeth R. GPs trial ‘digital assistants’. Health Informatics New Zealand, 28 September 2023.